ActiGraph Digital Data Summit 2022
Pensacola Beach, FL
Together, we can accelerate the impact of digital technologies on people's health
Building on the success of the inaugural virtual ActiGraph Digital Data Symposium last year, we are pleased to announce the ActiGraph Digital Data Summit 2022 will be held November 13-15 in Pensacola Beach, FL.
During this two-day event, speakers from diverse backgrounds across drug development, technology industries, and academia will share real-world experiences, lessons learned, and visions for the future of wearable technology in clinical research and care. We believe these cross-disciplinary dialogues will inspire new initiatives and collaborations to accelerate the impact of digital technologies on people's health.
ADDS 2022 Keynote and Featured Speakers
Principal Executive Officer/Chief Regulatory, Safety and Quality Officer
Carrie Northcott, PhD
Eric Perakslis, PhD
Chief Science and Digital Officer
Duke Clinical Research Institute
Dr. Rohit Aggarwal, MD, MS
University of Pittsburgh
Michelle Crouthamel DBA
Head of Digital Science
Jonas Dorn, PhD
Digital Biomarker Tech Lead
Richard Keefe, PhD
Professor of Psychiatry, Psychology, and Neurosciences
Duke University Medical Center
Tina Duong, PT, PhD
Director of Clinical Outcomes Research and Development
Stanford University Neuromuscular Division
Sr. Mgr. Clinical Outcomes Assessment
ADDS 2022 Highlights
Client Case Studies
Scientific Poster Session
ADDS 2022 Scientific Poster Session
During the ADDS 2022 Scientific Poster Session, a small group of accomplished students will present their original research using ActiGraph technology. After carefully considering all abstract submissions, student sponsorships will be awarded based on selections from ActiGraph's scientific review committee.
Lifetime Achievement Award to Dr. Patty Freedson
During ADDS 2022, ActiGraph will have the great honor of presenting Dr. Patty Freedson with a Lifetime Achievement Award in recognition of her immeasurable contributions to the field of actigraphy. Please join us in celebrating Dr. Freedson's accomplishments as we continue to work toward advancing clinical outcome measures throughout all areas of clinical research.